420 related articles for article (PubMed ID: 26045165)
1. Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway.
Li Y; Zhou H; Li F; Chan SW; Lin Z; Wei Z; Yang Z; Guo F; Lim CJ; Xing W; Shen Y; Hong W; Long J; Zhang M
Cell Res; 2015 Jul; 25(7):801-17. PubMed ID: 26045165
[TBL] [Abstract][Full Text] [Related]
2. Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.
Li W; You L; Cooper J; Schiavon G; Pepe-Caprio A; Zhou L; Ishii R; Giovannini M; Hanemann CO; Long SB; Erdjument-Bromage H; Zhou P; Tempst P; Giancotti FG
Cell; 2010 Feb; 140(4):477-90. PubMed ID: 20178741
[TBL] [Abstract][Full Text] [Related]
3. NEDD4L-mediated Merlin ubiquitination facilitates Hippo pathway activation.
Wei Y; Yee PP; Liu Z; Zhang L; Guo H; Zheng H; Anderson B; Gulley M; Li W
EMBO Rep; 2020 Dec; 21(12):e50642. PubMed ID: 33058421
[TBL] [Abstract][Full Text] [Related]
4. Molecular insights into NF2/Merlin tumor suppressor function.
Cooper J; Giancotti FG
FEBS Lett; 2014 Aug; 588(16):2743-52. PubMed ID: 24726726
[TBL] [Abstract][Full Text] [Related]
5. Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.
Li W; Cooper J; Zhou L; Yang C; Erdjument-Bromage H; Zagzag D; Snuderl M; Ladanyi M; Hanemann CO; Zhou P; Karajannis MA; Giancotti FG
Cancer Cell; 2014 Jul; 26(1):48-60. PubMed ID: 25026211
[TBL] [Abstract][Full Text] [Related]
6. A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions.
Yi C; Troutman S; Fera D; Stemmer-Rachamimov A; Avila JL; Christian N; Persson NL; Shimono A; Speicher DW; Marmorstein R; Holmgren L; Kissil JL
Cancer Cell; 2011 Apr; 19(4):527-40. PubMed ID: 21481793
[TBL] [Abstract][Full Text] [Related]
7. Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4 (DCAF1).
Li W; Giancotti FG
Cell Cycle; 2010 Nov; 9(22):4433-6. PubMed ID: 21084862
[TBL] [Abstract][Full Text] [Related]
8. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
9. Merlin/NF2 functions upstream of the nuclear E3 ubiquitin ligase CRL4DCAF1 to suppress oncogenic gene expression.
Cooper J; Li W; You L; Schiavon G; Pepe-Caprio A; Zhou L; Ishii R; Giovannini M; Hanemann CO; Long SB; Erdjument-Bromage H; Zhou P; Tempst P; Giancotti FG
Sci Signal; 2011 Aug; 4(188):pt6. PubMed ID: 21878678
[TBL] [Abstract][Full Text] [Related]
10. PIP5Kγ Mediates PI(4,5)P2/Merlin/LATS1 Signaling Activation and Interplays with Hsc70 in Hippo-YAP Pathway Regulation.
Le DDT; Le TPH; Lee SY
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834234
[TBL] [Abstract][Full Text] [Related]
11. Actin-binding and cell proliferation activities of angiomotin family members are regulated by Hippo pathway-mediated phosphorylation.
Chan SW; Lim CJ; Guo F; Tan I; Leung T; Hong W
J Biol Chem; 2013 Dec; 288(52):37296-307. PubMed ID: 24225952
[TBL] [Abstract][Full Text] [Related]
12. Shedding light on Merlin's wizardry.
Okada T; You L; Giancotti FG
Trends Cell Biol; 2007 May; 17(5):222-9. PubMed ID: 17442573
[TBL] [Abstract][Full Text] [Related]
13. Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1.
Le TPH; Nguyen NTT; Le DDT; Anwar MA; Lee SY
Cell Commun Signal; 2023 Jun; 21(1):149. PubMed ID: 37337213
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of DDB1-and-Cullin 4-associated Factor 1 (DCAF1) recognition by merlin/NF2 and its implication in tumorigenesis by CD44-mediated inhibition of merlin suppression of DCAF1 function.
Mori T; Gotoh S; Shirakawa M; Hakoshima T
Genes Cells; 2014 Aug; 19(8):603-19. PubMed ID: 24912773
[TBL] [Abstract][Full Text] [Related]
15. β1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin.
Sabra H; Brunner M; Mandati V; Wehrle-Haller B; Lallemand D; Ribba AS; Chevalier G; Guardiola P; Block MR; Bouvard D
J Biol Chem; 2017 Nov; 292(47):19179-19197. PubMed ID: 28972170
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
Laulajainen M; Muranen T; Carpén O; Grönholm M
Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
[TBL] [Abstract][Full Text] [Related]
17. NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.
Sato T; Sekido Y
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587439
[TBL] [Abstract][Full Text] [Related]
18. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.
Yin F; Yu J; Zheng Y; Chen Q; Zhang N; Pan D
Cell; 2013 Sep; 154(6):1342-55. PubMed ID: 24012335
[TBL] [Abstract][Full Text] [Related]
19. [Research progress of Merlin protein and its signal pathway in tumor].
Zhu YJ; Shan CG
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(9):757-762. PubMed ID: 29771032
[TBL] [Abstract][Full Text] [Related]
20. Merlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive Pathway that Is Cell-Density Dependent and Hippo Independent.
Hikasa H; Sekido Y; Suzuki A
Cell Rep; 2016 Mar; 14(12):2950-61. PubMed ID: 26997273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]